Joint Formulary & PAD

Prednisolone - Adrenal insufficiency

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important
Preferred
Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
 

Status 2

Blue
Formulations :
  • Soluble tablets
Associated Icons :
BNF SPC
R
Restrictions / Comments :
Important
For patients unable to swallow solid dose forms. Requests for primary care prescribing after 1st month supply and stabilisation by specialist team.
 

Status 3

Blue
Formulations :
  • Oral solution
Associated Icons :
Restrictions / Comments :
Important
For use in patients who are unable to swallow solid dose forms. Request for primary care prescribing after initiation and stabilisation - at least 1 month supply from specialist team.
 

Status 4

Non Formulary
Formulations :
  • Enteric coated tablets
Associated Icons :
BNF SPC
NFD1
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Prednisolone
Indication :
Adrenal insufficiency
Group Name :
Keywords :
Addison's disease
Brand Names Include :
Important Information :
- Prednisolone is an alternative treatment for use where multiple daily doses of hydrocortisone are not appropriate. - See PAD for guidance on providing reserve supplies for dosing during acute illness
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
4

Other Indications

Below are listed other indications that Prednisolone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Adrenal insufficiency.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) agrees the following place in therapy for glucocorticoids in line with NG243 (Adrenal insufficiency: identification and management)

  • Hydrocortidsone immediate release is the first choice glucocorticoid.
  • Prednisolone is an alternative first line if multiple daily doses are not appropriate.
  • Hydrocortisone modified-release is a 2nd line option
  • Fludrocortisone for mineralocorticoid replacement if needed (to normalise serum electrolytes and plasma renin, and reduce postural symptoms and salt craving)

See Formulary status and restrictions for individual formulations.

Dosing of glucocorticoids during acute illness - It is important for people with adrenal insufficiency to increase their corticosteroid doses at times of illness in order to reduce the risk of adrenal crisis. As a guide, for any moderate intercurrent illness (such as illness with fever, requiring bedrest, or requiring antibiotics), they should double their usual doses of Hydrocortisone until recovered, or if on Prednisolone, they should increase to a minimum dose of 10 mg daily (or follow specific advice as recommended by their specialist).

In order to allow patients to promptly increase their corticosteroid dose at times of need, and to avoid any risk from unexpected supply shortages, patients should ideally retain 2 months reserve supply at all times and should be reminded to renew their prescription in good time.